2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence

TY Wong, C Sabanayagam - Ophthalmologica, 2020 - karger.com
Diabetes is a global public health disease projected to affect 642 million adults by 2040, with
about 75% residing in low-and middle-income countries. Diabetic retinopathy (DR) affects 1 …

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes …

MS Capehorn, AM Catarig, JK Furberg, A Janez… - Diabetes & …, 2020 - Elsevier
Aims SUSTAIN 10 compared the efficacy and safety of the anticipated most frequent
semaglutide dose (1.0 mg) with the current most frequently prescribed liraglutide dose in …

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature

P Katulanda, HA Dissanayake, I Ranathunga… - Diabetologia, 2020 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has emerged as one of the
greatest challenges faced by humankind in the recent past. People with diabetes and …

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020Table. No title available.

R Chawla, SV Madhu, BM Makkar… - Indian journal of …, 2020 - journals.lww.com
Guidelines RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2
Diabetes Mellitus 2020Table. No title available.

[HTML][HTML] Adipose tissue: physiology to metabolic dysfunction

AJ Richard, U White, CM Elks, JM Stephens - Endotext [Internet], 2020 - ncbi.nlm.nih.gov
Like the obesity epidemic, our understanding of adipocytes and adipose tissue is
expanding. Just in the past decade, substantial advances have led to new insights into the …

Chrono-nutrition for the prevention and treatment of obesity and type 2 diabetes: from mice to men

JA Hawley, P Sassone-Corsi, JR Zierath - Diabetologia, 2020 - Springer
The proliferation in the rate of diagnosis of obesity and type 2 diabetes mellitus continues
unabated, with current recommendations for primary lifestyle changes (ie modification to …

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled …

D Yabe, J Nakamura, H Kaneto… - The Lancet Diabetes & …, 2020 - thelancet.com
Background New glucose-lowering medications need to be investigated in east Asian
populations, as the clinical characteristics of type 2 diabetes differ between western and east …

Сахарный диабет 2 типа у взрослых

ИИ Дедов, МВ Шестакова, АЮ Майоров… - Сахарный …, 2020 - dia-endojournals.ru
1.1 ОПРЕДЕЛЕНИЕ ЗАБОЛЕВАНИЯ ИЛИ СОСТОЯНИЯ (ГРУППЫ ЗАБОЛЕВАНИЙ ИЛИ
СОСТОЯНИЙ) 7 1.2 ЭТИОЛОГИЯ И ПАТОГЕНЕЗ ЗАБОЛЕВАНИЯ ИЛИ СОСТОЯНИЯ …

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre …

ACG van Baar, F Holleman, L Crenier, R Haidry… - Gut, 2020 - gut.bmj.com
Background The duodenum has become a metabolic treatment target through bariatric
surgery learnings and the specific observation that bypassing, excluding or altering …